The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.本發明提供式(I)化合物，或其立體異構物、互變異構物或醫藥上可接受之鹽，其中所有變量皆如本文所定義。該等化合物係選擇性ROCK抑制劑。本發明亦係關於包含該等化合物之醫藥組合物及使用該等醫藥組合物治療心血管、平滑肌、腫瘤學、神經病理學、自體免疫、纖維變性及/或發炎病症之方法。
